Signaling Mechanisms of SARS-CoV-2 Nucleocapsid Protein in Viral Infection, Cell Death and Inflammation
Overview
Authors
Affiliations
COVID-19 which is caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) has posed a worldwide pandemic and a major global public health threat. SARS-CoV-2 Nucleocapsid (N) protein plays a critical role in multiple steps of the viral life cycle and participates in viral replication, transcription, and assembly. The primary roles of N protein are to assemble with genomic RNA into the viral RNA-protein (vRNP) complex and to localize to the replication transcription complexes (RTCs) to enhance viral replication and transcription. N protein can also undergo liquid-liquid phase separation (LLPS) with viral genome RNA and inhibit stress granules to facilitate viral replication and assembly. Besides the function in viral life cycle, N protein can bind GSDMD to antagonize pyroptosis but promotes cell death via the Smad3-dependent G1 cell cycle arrest mechanism. In innate immune system, N protein inhibits IFN-β production and RNAi pathway for virus survival. However, it can induce expression of proinflammatory cytokines by activating NF-κB signaling and NLRP3 inflammasome, resulting in cytokine storms. In this review article, we are focusing on the signaling mechanisms of SARS-CoV-2 N protein in viral replication, cell death and inflammation.
Zhou W, Li H, Zhang J, Liu C, Liu D, Chen X Ann Med. 2025; 57(1):2477301.
PMID: 40074706 PMC: 11905318. DOI: 10.1080/07853890.2025.2477301.
A20 as a Potential Therapeutic Target for COVID-19.
Wu Y, He L, Li R, Li J, Zhao Q, Shao B Immun Inflamm Dis. 2025; 13(1):e70127.
PMID: 39853876 PMC: 11760982. DOI: 10.1002/iid3.70127.
SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis.
Guo X, Yang S, Cai Z, Zhu S, Wang H, Liu Q J Cell Biol. 2024; 224(1).
PMID: 39680116 PMC: 11648720. DOI: 10.1083/jcb.202404131.
Pedreanez A, Mosquera-Sulbaran J, Tene D Diabetol Int. 2024; 15(4):732-744.
PMID: 39469543 PMC: 11512988. DOI: 10.1007/s13340-024-00746-1.
Pretreatment can alleviate programmed cell death in mesenchymal stem cells.
Wan X, Hu X, Zhang Q, Xiong K World J Stem Cells. 2024; 16(8):773-779.
PMID: 39219726 PMC: 11362856. DOI: 10.4252/wjsc.v16.i8.773.